Cargando…

The use of venous Doppler to predict adverse kidney events in a general ICU cohort

BACKGROUND: Changes in Doppler flow patterns of hepatic veins (HV), portal vein (PV) and intra-renal veins (RV) reflect right atrial pressure and venous congestion; the feasibility of obtaining these assessments and the clinical relevance of the findings is unknown in a general ICU population. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Spiegel, Rory, Teeter, William, Sullivan, Scott, Tupchong, Keegan, Mohammed, Nabeel, Sutherland, Mark, Leibner, Evan, Rola, Philippe, Galvagno, Samuel M., Murthi, Sarah B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574322/
https://www.ncbi.nlm.nih.gov/pubmed/33076961
http://dx.doi.org/10.1186/s13054-020-03330-6
_version_ 1783597617703288832
author Spiegel, Rory
Teeter, William
Sullivan, Scott
Tupchong, Keegan
Mohammed, Nabeel
Sutherland, Mark
Leibner, Evan
Rola, Philippe
Galvagno, Samuel M.
Murthi, Sarah B.
author_facet Spiegel, Rory
Teeter, William
Sullivan, Scott
Tupchong, Keegan
Mohammed, Nabeel
Sutherland, Mark
Leibner, Evan
Rola, Philippe
Galvagno, Samuel M.
Murthi, Sarah B.
author_sort Spiegel, Rory
collection PubMed
description BACKGROUND: Changes in Doppler flow patterns of hepatic veins (HV), portal vein (PV) and intra-renal veins (RV) reflect right atrial pressure and venous congestion; the feasibility of obtaining these assessments and the clinical relevance of the findings is unknown in a general ICU population. This study compares the morphology of HV, PV and RV waveform abnormalities in prediction of major adverse kidney events at 30 days (MAKE30) in critically ill patients. STUDY DESIGN AND METHODS: We conducted a prospective observational study enrolling adult patients within 24 h of admission to the ICU. Patients underwent an ultrasound evaluation of the HV, PV and RV. We compared the rate of MAKE-30 events in patients with and without venous flow abnormalities in the hepatic, portal and intra-renal veins. The HV was considered abnormal if S to D wave reversal was present. The PV was considered abnormal if the portal pulsatility index (PPI) was greater than 30%. We also examined PPI as a continuous variable to assess whether small changes in portal vein flow was a clinically important marker of venous congestion. RESULTS: From January 2019 to June 2019, we enrolled 114 patients. HV abnormalities demonstrate an odds ratio of 4.0 (95% CI 1.4–11.2). PV as a dichotomous outcome is associated with an increased odds ratio of MAKE-30 but fails to reach statistical significance (OR 2.3 95% CI 0.87–5.96), but when examined as a continuous variable it demonstrates an odds ratio of 1.03 (95% CI 1.00–1.06). RV Doppler flow abnormalities are not associated with an increase in the rate of MAKE-30 INTERPRETATION: Obtaining hepatic, portal and renal venous Doppler assessments in critically ill ICU patients are feasible. Abnormalities in hepatic and portal venous Doppler are associated with an increase in MAKE-30. Further research is needed to determine if venous Doppler assessments can be useful measures in assessing right-sided venous congestion in critically ill patients.
format Online
Article
Text
id pubmed-7574322
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-75743222020-10-20 The use of venous Doppler to predict adverse kidney events in a general ICU cohort Spiegel, Rory Teeter, William Sullivan, Scott Tupchong, Keegan Mohammed, Nabeel Sutherland, Mark Leibner, Evan Rola, Philippe Galvagno, Samuel M. Murthi, Sarah B. Crit Care Research BACKGROUND: Changes in Doppler flow patterns of hepatic veins (HV), portal vein (PV) and intra-renal veins (RV) reflect right atrial pressure and venous congestion; the feasibility of obtaining these assessments and the clinical relevance of the findings is unknown in a general ICU population. This study compares the morphology of HV, PV and RV waveform abnormalities in prediction of major adverse kidney events at 30 days (MAKE30) in critically ill patients. STUDY DESIGN AND METHODS: We conducted a prospective observational study enrolling adult patients within 24 h of admission to the ICU. Patients underwent an ultrasound evaluation of the HV, PV and RV. We compared the rate of MAKE-30 events in patients with and without venous flow abnormalities in the hepatic, portal and intra-renal veins. The HV was considered abnormal if S to D wave reversal was present. The PV was considered abnormal if the portal pulsatility index (PPI) was greater than 30%. We also examined PPI as a continuous variable to assess whether small changes in portal vein flow was a clinically important marker of venous congestion. RESULTS: From January 2019 to June 2019, we enrolled 114 patients. HV abnormalities demonstrate an odds ratio of 4.0 (95% CI 1.4–11.2). PV as a dichotomous outcome is associated with an increased odds ratio of MAKE-30 but fails to reach statistical significance (OR 2.3 95% CI 0.87–5.96), but when examined as a continuous variable it demonstrates an odds ratio of 1.03 (95% CI 1.00–1.06). RV Doppler flow abnormalities are not associated with an increase in the rate of MAKE-30 INTERPRETATION: Obtaining hepatic, portal and renal venous Doppler assessments in critically ill ICU patients are feasible. Abnormalities in hepatic and portal venous Doppler are associated with an increase in MAKE-30. Further research is needed to determine if venous Doppler assessments can be useful measures in assessing right-sided venous congestion in critically ill patients. BioMed Central 2020-10-19 /pmc/articles/PMC7574322/ /pubmed/33076961 http://dx.doi.org/10.1186/s13054-020-03330-6 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Spiegel, Rory
Teeter, William
Sullivan, Scott
Tupchong, Keegan
Mohammed, Nabeel
Sutherland, Mark
Leibner, Evan
Rola, Philippe
Galvagno, Samuel M.
Murthi, Sarah B.
The use of venous Doppler to predict adverse kidney events in a general ICU cohort
title The use of venous Doppler to predict adverse kidney events in a general ICU cohort
title_full The use of venous Doppler to predict adverse kidney events in a general ICU cohort
title_fullStr The use of venous Doppler to predict adverse kidney events in a general ICU cohort
title_full_unstemmed The use of venous Doppler to predict adverse kidney events in a general ICU cohort
title_short The use of venous Doppler to predict adverse kidney events in a general ICU cohort
title_sort use of venous doppler to predict adverse kidney events in a general icu cohort
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574322/
https://www.ncbi.nlm.nih.gov/pubmed/33076961
http://dx.doi.org/10.1186/s13054-020-03330-6
work_keys_str_mv AT spiegelrory theuseofvenousdopplertopredictadversekidneyeventsinageneralicucohort
AT teeterwilliam theuseofvenousdopplertopredictadversekidneyeventsinageneralicucohort
AT sullivanscott theuseofvenousdopplertopredictadversekidneyeventsinageneralicucohort
AT tupchongkeegan theuseofvenousdopplertopredictadversekidneyeventsinageneralicucohort
AT mohammednabeel theuseofvenousdopplertopredictadversekidneyeventsinageneralicucohort
AT sutherlandmark theuseofvenousdopplertopredictadversekidneyeventsinageneralicucohort
AT leibnerevan theuseofvenousdopplertopredictadversekidneyeventsinageneralicucohort
AT rolaphilippe theuseofvenousdopplertopredictadversekidneyeventsinageneralicucohort
AT galvagnosamuelm theuseofvenousdopplertopredictadversekidneyeventsinageneralicucohort
AT murthisarahb theuseofvenousdopplertopredictadversekidneyeventsinageneralicucohort
AT spiegelrory useofvenousdopplertopredictadversekidneyeventsinageneralicucohort
AT teeterwilliam useofvenousdopplertopredictadversekidneyeventsinageneralicucohort
AT sullivanscott useofvenousdopplertopredictadversekidneyeventsinageneralicucohort
AT tupchongkeegan useofvenousdopplertopredictadversekidneyeventsinageneralicucohort
AT mohammednabeel useofvenousdopplertopredictadversekidneyeventsinageneralicucohort
AT sutherlandmark useofvenousdopplertopredictadversekidneyeventsinageneralicucohort
AT leibnerevan useofvenousdopplertopredictadversekidneyeventsinageneralicucohort
AT rolaphilippe useofvenousdopplertopredictadversekidneyeventsinageneralicucohort
AT galvagnosamuelm useofvenousdopplertopredictadversekidneyeventsinageneralicucohort
AT murthisarahb useofvenousdopplertopredictadversekidneyeventsinageneralicucohort